• °æºÎ °áÇÙ¼º ÀÓÆļ±¿°ÀÇ ÀÓ»óÀû ºÐ¼®

• Clinical Analysis of Tuberculous Cervical Lymphadenitis

• ¼Û´Þ¿ø

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  4461 ~ 467

• ÀÌ»ó°æ»óµ¹±âÁõ 3·Ê

• Three Cases of Elongated Styloid Process

• ¾Èº´ÈÆ

• ±è´öÁØ/¼Õ¿µÅ¹/Áöº´ÁØ/¼Û´Þ¿ø/¹æ¼ºÇõ

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  493 ~ 498

• 1Çü ³ª¹ÝÀÀÀ» µ¿¹ÝÇÑ ±Ù°áÇپ糪 1·Ê

• A Case of Borderline Tuberculoid Leprosy with Type 1 Reaction

• ³ë¿ëÁö

• ÃÖÀ±¾Ö, ±è±ÍºÐ, ±è¼ºÈ¯

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  488 ~ 492

• ü¿Ü¼öÁ¤ ¹× ¹è¾ÆÀÇ Àڱó» À̽Ä

• In Vitro Fetilization and Embryo Transfer

• À̵ηæ

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  482 ~ 487

• AlobarÇü Holoprosencephaly 1·Ê

• A Case of Alobar Holoprosencephaly

• Çã»ó¸í

• ¼­Àº¼÷, ¹Úâȣ, ±èÈ«¿­

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  474 ~ 481

• »óºÎÀÔ¼ú¿¡¼­ ¹ß»ýÇÑ Adenoid Cystic Carcinoma 1·Ê

• Adenoid Cystic Carcinoma of the Upper-Lip

• ¼Û¼öÀÎ

• ÇÑ⿱/¼ÛÈ«¼®/¼ÛÁß¾ð/±Ç°Ç¿µ

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  468 ~ 473

• °æºÎ °áÇÙ¼º ÀÓÆļ±¿°ÀÇ ÀÓ»óÀû ºÐ¼®

• Clinical Analysis of Tuberculous Cervical Lymphadenitis

• ¼Û´Þ¿ø

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  461 ~ 467

• ´ç´¢º´È¯ÀÚ¿¡ À־ Ä¡·á¹æ¹ý ¼±Á¤¿¡ ½ÄÈÄ 2½Ã°£ Ç÷û C-peptideÄ¡¿Í Glucagon ÀÚ±ØÈÄ Ç÷û C-peptideÄ¡ÀÇ...

• Glucagon-Stimulated and Postprandial Plasma C-peptide Values as a Guide for Insulin Treatment in Pat...

• ¼­¿µ¼÷

• ¼Õ¼öÀÎ/ÀÌÀαÔ/¾È¼ºÈÆ/ÀÌÇü¿ì/ÀÌÇö¿ì

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  455 ~ 460

• ¿øÀÎºÒ¸í ¹× ¹«¹è¶õ¼º ºÒÀÓȯÀÚ¿¡ À־ ¹è¶õÀ¯µµ¿¡ ÀÇÇØ ¹ß»ýÇÏ´Â ³­¼Ò°úÀÛ±Ø ÁõÈıٿ¡ °üÇÑ ¿¬±¸

• Study on Ovarian Hyperstimulation Syndrome(OHSS) in Ovulation Induction for Unexplained and Anovulat...

• À̵ηæ

• Á¶Ä¡Èì, ÀÌÇ⸲

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  450 ~ 454

• °Ç¼± Ä¡·á½Ã Etretinate¿Í PUVAÀÇ º´¿ë¿ä¹ýÀÇ ´ëÇÑ ÀÓ»óÀû °íÂû

• Clinical Evaluation of Etretinate and PUVA Combination Therapy in Psoriasis

• ³ë¿ëÁö

• ÃÖÀ±¾Ö/¹ÚÀǼö/À̱Լ®/¼ÛÁØ¿µ

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  445 ~ 449

• À¯¾ÏÁ¶Á÷¿¡¼­ ´Ü¼¼Æ÷±ºÇ×ü¸¦ ÀÌ¿ëÇÑ ¸é¿ª¼¼Æ÷È­Çйý¿¡ ÀÇÇÑ ¿¡½ºÆ®·Î°Õ ¼ö¿ëüÀÇ ÃøÁ¤

• An Immunocytochemical Assay of Estrogen Receptor in Breast Cancers Using Monoclonal Antibodies

• ±èÀÎÈ£

• ±èÁ¾¿ì, À̱¤¼®, ¹éÅ¿ø

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  439 ~ 444

• ÀÚ±ÃÀ°Á¾ÀÇ ÀÓ»ó º´¸®ÇÐÀû °íÂû

• Clinicopathologic Study of the Uterine Sarcoma

• ÀÌŹ

• Â÷¼øµµ

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  434 ~ 438

• Ç÷¼ÒÆÇ °¨¼Ò ȯÀÚµéÀÇ Æò±Õ Ç÷¼ÒÆÇ¿ëÀû°ú Ç÷¼ÒÆÇ¿ëÀû ºÐÆ÷Æø

• Mean Platelet Volume and Platelet Distribution Width in Thrombocytopenic Patients

• ÃÖÀÎÀå

• ±èÀç·æ

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  429 ~ 433

• °è¸íÀÇ´ë ³í¹® 1335ÆíÀÇ ºÐ¼®°ú ÅäÀÇ

• An Analysis of Medical Research Works in Keimyung Medical School(1335 Cases)

• ÃÖÁ¤Àº

• °ûÁÖ°ß

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  418 ~ 428

• Àӻ󰡰˹°¿¡¼­ ºÐ¸®µÈ GramÀ½¼º °£±ÕÀÇ Ç×±ÕÁ¦°¨¼ö¼º

• Antimicrobial Durg Susceptibility of Gram Negative Bacilli Isolated from Clinical Specimens

• ¹é¿ø±â

• ¼­¼ºÀÏ, ÀÓÁ¤±Ù

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  409 ~ 417

• ´ë±¸½Ã Áֹε鿡 À־ ¸ð³¶ÃæÀÇ À¯º´À²

• Prevalence of Demodicidosis among Residents in Taegu City

• ±è±¤ÅÂ

• ±è»óÇ¥, ÀÌ»ó±Ç

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  4È£  401 ~ 408

• À¯À°Á¾Áõ 3·Ê

• Three Cases of Sarcoidosis

• ÃÖµ¿ÇÏ

• Àü¿µÁØ, ÁÖÀÏ, ¼Õ¼öÀÎ, ÀåÀº¼÷, ÀÌ¿µÀç

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  3È£  390 ~ 398

• ¸¸¼º°æ°úÀÇ Æó·ÅÀ» µ¿¹ÝÇÑ ±â°üÁö°á¼®Áõ 1·Ê

• Broncholithiasis: Report of One Case

• ÀÌÇ念

• Àü¼®±¸/³²°èÀ±/Àü¿µÁØ/Ȳ¼®¼ø

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  3È£  386 ~ 389

• ÈıÃÀ» ħ¹üÇÑ Ã´Ãß°áÇÙ 1·Ê

• A Case of Spinal Tuberculosis with Posterior Element Involvement

• Æí¿µ½Ä

• ¼Û±¤¼ø, ³ëÅ¿¬

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  3È£  380 ~ 385

• Virus Associated Homophagocytic Syndrome 3·Ê

• 3 Cases of Virus Associated Hemophagocytic Syndrome

• ȲÁ¾¹®

• ±èÁؽÄ/¼­Àº¼÷/°­Áø¹«/Àüµ¿¼®

• °è¸íÀÇ´ë³í¹®Áý   1990³â  9±Ç  3È£  369 ~ 379